4883 Modalis Therapeutics Corporation - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4883

TSE Growth

Modalis Therapeutics Corporation

JPY

-1

(-1.32%)

May 2, 3:30 pm JST

0.51

USD

May 2, 2:30 am EDT

Result

ー

PTS

outside of trading hours

May 2, 11:47 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2021	1	-1,239	-1,231	-738	-25.7	0	Feb 14, 2022	J-GAAP
Dec, 2022	40	-2,063	-1,995	-2,702	-92.9	0	Feb 13, 2023	J-GAAP
Dec, 2023	0	-2,370	-2,351	-2,391	-77.2	0	Feb 14, 2024	J-GAAP
Dec, 2024	0	-1,337	-1,303	-1,317	-28.6	0	Feb 13, 2025	J-GAAP
Dec, 2025 Guidance	ー	ー	ー	ー	－	0	Feb 13, 2025	J-GAAP
YoY	－	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Dec, 2020	Aug 3, 2020	1,100	350	300	250	－	J-GAAP
-	Aug 14, 2020	1,100	350	300	250	0	J-GAAP
	Dec 15, 2020	342	-420	-463	-471	0	J-GAAP
Results	Feb 12, 2021	342	-398	-439	-448	0	J-GAAP
Dec, 2021	Feb 12, 2021	Available in future release
Results	Feb 14, 2022
Dec, 2022	Feb 14, 2022
Results	Feb 13, 2023
Dec, 2023	Feb 13, 2023
Results	Feb 14, 2024
Dec, 2024	Feb 14, 2024
Results	Feb 13, 2025
Dec, 2025	Feb 13, 2025	ー	ー	ー	ー	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Dec, 2016	ー	－	Available in future release
Dec, 2017	17	－
Dec, 2018	65	+282.4
Dec, 2019	644	+890.8
Dec, 2020	342	-46.9
Dec, 2021	1	-99.7
Dec, 2022	40	+3,900.0
Dec, 2023	0	-100.0
Dec, 2024	0	－
Dec, 2025 Guidance	ー	－	ー	+100.0	ー	+100.0	－	+100.0

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Dec, 2023	0	-2,370	ー	-111.86	-92.78	ー	-77.2
Dec, 2024	0	-1,337	ー	-53.99	-46.08	ー	-28.6
Dec, 2025 Guidance	ー	ー	ー	ー	ー	ー	－

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	644	157	146	140	6.0
Fiscal Year	Dec, 2019	Dec, 2019	Dec, 2019	Dec, 2019	Dec, 2019

First Half

Result

Guidance History

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan - Jun, 2022	40	-868	-780	-775	-26.7	0	Aug 5, 2022	J-GAAP
Jan - Jun, 2023	0	-1,044	-995	-1,033	-34.7	0	Aug 7, 2023	J-GAAP
Jan - Jun, 2024	0	-838	-780	-780	-22.0	0	Aug 7, 2024	J-GAAP
Jan - Jun, 2025 Guidance	ー	ー	ー	ー	－	0	Feb 13, 2025	J-GAAP
YoY	－	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jun, 2022	Feb 14, 2022	ー	ー	ー	ー	0	J-GAAP
- - - - Results	Aug 5, 2022	40	-868	-780	-775	0	J-GAAP
Jun, 2023	Feb 13, 2023	Available in future release
Results	Aug 7, 2023
Jun, 2024	Feb 14, 2024
Results	Aug 7, 2024
Jun, 2025	Feb 13, 2025	ー	ー	ー	ー	0	J-GAAP

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Dec, 2022	-2,063	-2,080	-1,895	-185	63	2,933	93.74	J-GAAP
Dec, 2023	-2,370	-2,293	-2,254	-39	1,216	1,883	92.99	J-GAAP
Dec, 2024	-1,337	-1,432	-1,432	0	3,044	3,575	96.86	J-GAAP

Actual Performance and Financial Trends

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	40	-2,063	-1,995	-2,702	-92.9	0	Feb 13, 2023	J-GAAP
Dec, 2023	0	-2,370	-2,351	-2,391	-77.2	0	Feb 14, 2024	J-GAAP
Dec, 2024	0	-1,337	-1,303	-1,317	-28.6	0	Feb 13, 2025	J-GAAP
YoY	－	+43.6%	+44.6%	+44.9%	+63.0%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2023	0	-514	-509	-532	-17.9	-Inf	May 9, 2023	J-GAAP
Apr - Jun, 2023	0	-530	-486	-501	-16.8	-Inf	Aug 7, 2023	J-GAAP
Jul - Sep, 2023	0	-565	-547	-548	-18.1	-Inf	Nov 7, 2023	J-GAAP
Oct - Dec, 2023	0	-761	-809	-810	-26.2	-Inf	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	0	-490	-457	-457	-13.6	-Inf	May 8, 2024	J-GAAP
Apr - Jun, 2024	0	-348	-323	-323	-9.1	-Inf	Aug 7, 2024	J-GAAP
Jul - Sep, 2024	0	-224	-279	-280	-7.2	-Inf	Nov 7, 2024	J-GAAP
Oct - Dec, 2024	0	-275	-244	-257	-5.6	-Inf	Feb 13, 2025	J-GAAP
YoY	－	+63.9%	+69.8%	+68.3%	+78.7%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2020	13	－	Available in future release
Apr - Jun, 2020	324	－
Jul - Sep, 2020	3	－
Oct - Dec, 2020	2	－
Jan - Mar, 2021	0	-100.0
Apr - Jun, 2021	1	-99.7
Jul - Sep, 2021	0	-100.0
Oct - Dec, 2021	0	-100.0
Jan - Mar, 2022	40	－
Apr - Jun, 2022	0	-100.0
Jul - Sep, 2022	0	－
Oct - Dec, 2022	0	－
Jan - Mar, 2023	0	-100.0
Apr - Jun, 2023	0	－
Jul - Sep, 2023	0	－
Oct - Dec, 2023	0	－
Jan - Mar, 2024	0	－
Apr - Jun, 2024	0	－
Jul - Sep, 2024	0	－
Oct - Dec, 2024	0	－	-275	+63.9	-244	+69.8	-5.6	+78.6

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	324	154	145	201	7.1
Fiscal Year	Jun, 2020	Jun, 2020	Jun, 2020	Mar, 2021	Mar, 2021

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Dec, 2022	99.53	93.4	3,129	2,922	-2,605	ー	Feb 13, 2023	J-GAAP
Dec, 2023	40.59	66.8	2,025	1,353	-2,410	0.30	Feb 14, 2024	J-GAAP
Dec, 2024	50.81	95.5	3,691	3,526	-1,325	ー	Feb 13, 2025	J-GAAP

Modalis Therapeutics Corporation(4883) Financial Results